Professor Zoran Rankovic’s group is developing PROTACs, Molecular Glue Degraders, and E3 ubiquitin ligase chemical probes to study cancer biology and develop novel cancer drugs.
Professor Zoran Rankovic is Director of the Centre for Protein Degradation. He applies his targeted protein degradation, medicinal chemistry, and drug discovery expertise gained over 25 years of research in both industry and academia to discover and develop novel cancer treatments.